Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,277.51 +42.03 (+0.80%) Dow
38,686.32 +574.82 (+1.51%) Nasdaq
16,735.02 -2.08 (-0.01%) Bitcoin USD
69,606.09 +1,754.94 (+2.59%) CMC Crypto 200
1,499.25 +31.32 (+2.13%)
Fresenius SE & Co. KGaA (FRE.F)
| Previous close | 29.20 |
| Open | 29.30 |
| Bid | 29.23 x N/A |
| Ask | 29.24 x N/A |
| Day's range | 29.25 - 29.43 |
| 52-week range | 24.06 - 31.15 |
| Volume | |
| Avg. volume | 2,586 |
| Market cap | 16.52B |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | 39.53 |
| EPS (TTM) | 0.74 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.92 (3.22%) |
| Ex-dividend date | 18 May 2023 |
| 1y target est | 13.74 |
Simply Wall St.Investors five-year losses continue as Fresenius SE KGaA (ETR:FRE) dips a further 3.8% this week, earnings continue to decline
The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
- Simply Wall St.
Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
